GMAN Newsletter – August 2015

  Vol.1 Issue 4 gman.myeloma.org August, 2015   European Medicines Agency Grants Accelerated Review of Ixazomib The European Medicines Agency (EMA) recently granted Takeda Pharmaceutical Company’s investigational multiple myeloma drug ixazomib an accelerated review. The EMA gives accelerated assessment for drugs that it believes are of major public health interest, or innovation, in order to expedite […]